table of content
1 Introduction to Research & Analysis Reports
1.1 Living Biological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Living Biological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Living Biological Drugs Overall Market Size
2.1 Global Living Biological Drugs Market Size: 2022 VS 2030
2.2 Global Living Biological Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Living Biological Drugs Players in Global Market
3.2 Top Global Living Biological Drugs Companies Ranked by Revenue
3.3 Global Living Biological Drugs Revenue by Companies
3.4 Top 3 and Top 5 Living Biological Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Living Biological Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Living Biological Drugs Players in Global Market
3.6.1 List of Global Tier 1 Living Biological Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Living Biological Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Living Biological Drugs Market Size Markets, 2022 & 2030
4.1.2 Single Strain
4.1.3 Multi Strain
4.1.4 Co-Culture
4.2 By Type - Global Living Biological Drugs Revenue & Forecasts
4.2.1 By Type - Global Living Biological Drugs Revenue, 2018-2023
4.2.2 By Type - Global Living Biological Drugs Revenue, 2023-2030
4.2.3 By Type - Global Living Biological Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Living Biological Drugs Market Size, 2022 & 2030
5.1.2 Digestive System
5.1.3 Urinary System
5.1.4 Skin System
5.2 By Application - Global Living Biological Drugs Revenue & Forecasts
5.2.1 By Application - Global Living Biological Drugs Revenue, 2018-2023
5.2.2 By Application - Global Living Biological Drugs Revenue, 2023-2030
5.2.3 By Application - Global Living Biological Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Living Biological Drugs Market Size, 2022 & 2030
6.2 By Region - Global Living Biological Drugs Revenue & Forecasts
6.2.1 By Region - Global Living Biological Drugs Revenue, 2018-2023
6.2.2 By Region - Global Living Biological Drugs Revenue, 2023-2030
6.2.3 By Region - Global Living Biological Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Living Biological Drugs Revenue, 2018-2030
6.3.2 US Living Biological Drugs Market Size, 2018-2030
6.3.3 Canada Living Biological Drugs Market Size, 2018-2030
6.3.4 Mexico Living Biological Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Living Biological Drugs Revenue, 2018-2030
6.4.2 Germany Living Biological Drugs Market Size, 2018-2030
6.4.3 France Living Biological Drugs Market Size, 2018-2030
6.4.4 U.K. Living Biological Drugs Market Size, 2018-2030
6.4.5 Italy Living Biological Drugs Market Size, 2018-2030
6.4.6 Russia Living Biological Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Living Biological Drugs Market Size, 2018-2030
6.4.8 Benelux Living Biological Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Living Biological Drugs Revenue, 2018-2030
6.5.2 China Living Biological Drugs Market Size, 2018-2030
6.5.3 Japan Living Biological Drugs Market Size, 2018-2030
6.5.4 South Korea Living Biological Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Living Biological Drugs Market Size, 2018-2030
6.5.6 India Living Biological Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Living Biological Drugs Revenue, 2018-2030
6.6.2 Brazil Living Biological Drugs Market Size, 2018-2030
6.6.3 Argentina Living Biological Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Living Biological Drugs Revenue, 2018-2030
6.7.2 Turkey Living Biological Drugs Market Size, 2018-2030
6.7.3 Israel Living Biological Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Living Biological Drugs Market Size, 2018-2030
6.7.5 UAE Living Biological Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Ardeypharman
7.1.1 Ardeypharman Corporate Summary
7.1.2 Ardeypharman Business Overview
7.1.3 Ardeypharman Living Biological Drugs Major Product Offerings
7.1.4 Ardeypharman Living Biological Drugs Revenue in Global Market (2018-2023)
7.1.5 Ardeypharman Key News
7.2 Miyarisan Pharmaceutical
7.2.1 Miyarisan Pharmaceutical Corporate Summary
7.2.2 Miyarisan Pharmaceutical Business Overview
7.2.3 Miyarisan Pharmaceutical Living Biological Drugs Major Product Offerings
7.2.4 Miyarisan Pharmaceutical Living Biological Drugs Revenue in Global Market (2018-2023)
7.2.5 Miyarisan Pharmaceutical Key News
7.3 Ferring Pharmaceuticals
7.3.1 Ferring Pharmaceuticals Corporate Summary
7.3.2 Ferring Pharmaceuticals Business Overview
7.3.3 Ferring Pharmaceuticals Living Biological Drugs Major Product Offerings
7.3.4 Ferring Pharmaceuticals Living Biological Drugs Revenue in Global Market (2018-2023)
7.3.5 Ferring Pharmaceuticals Key News
7.4 Seres Therapeutics
7.4.1 Seres Therapeutics Corporate Summary
7.4.2 Seres Therapeutics Business Overview
7.4.3 Seres Therapeutics Living Biological Drugs Major Product Offerings
7.4.4 Seres Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.4.5 Seres Therapeutics Key News
7.5 Infant Bacterial Therapeutics
7.5.1 Infant Bacterial Therapeutics Corporate Summary
7.5.2 Infant Bacterial Therapeutics Business Overview
7.5.3 Infant Bacterial Therapeutics Living Biological Drugs Major Product Offerings
7.5.4 Infant Bacterial Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.5.5 Infant Bacterial Therapeutics Key News
7.6 Osel
7.6.1 Osel Corporate Summary
7.6.2 Osel Business Overview
7.6.3 Osel Living Biological Drugs Major Product Offerings
7.6.4 Osel Living Biological Drugs Revenue in Global Market (2018-2023)
7.6.5 Osel Key News
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Living Biological Drugs Major Product Offerings
7.7.4 Takeda Living Biological Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Key News
7.8 AOBiome
7.8.1 AOBiome Corporate Summary
7.8.2 AOBiome Business Overview
7.8.3 AOBiome Living Biological Drugs Major Product Offerings
7.8.4 AOBiome Living Biological Drugs Revenue in Global Market (2018-2023)
7.8.5 AOBiome Key News
7.9 Synlogic
7.9.1 Synlogic Corporate Summary
7.9.2 Synlogic Business Overview
7.9.3 Synlogic Living Biological Drugs Major Product Offerings
7.9.4 Synlogic Living Biological Drugs Revenue in Global Market (2018-2023)
7.9.5 Synlogic Key News
7.10 Finch Therapeutics
7.10.1 Finch Therapeutics Corporate Summary
7.10.2 Finch Therapeutics Business Overview
7.10.3 Finch Therapeutics Living Biological Drugs Major Product Offerings
7.10.4 Finch Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.10.5 Finch Therapeutics Key News
7.11 Capsugel
7.11.1 Capsugel Corporate Summary
7.11.2 Capsugel Business Overview
7.11.3 Capsugel Living Biological Drugs Major Product Offerings
7.11.4 Capsugel Living Biological Drugs Revenue in Global Market (2018-2023)
7.11.5 Capsugel Key News
7.12 Jeneil Biotech
7.12.1 Jeneil Biotech Corporate Summary
7.12.2 Jeneil Biotech Business Overview
7.12.3 Jeneil Biotech Living Biological Drugs Major Product Offerings
7.12.4 Jeneil Biotech Living Biological Drugs Revenue in Global Market (2018-2023)
7.12.5 Jeneil Biotech Key News
7.13 UAS Labs
7.13.1 UAS Labs Corporate Summary
7.13.2 UAS Labs Business Overview
7.13.3 UAS Labs Living Biological Drugs Major Product Offerings
7.13.4 UAS Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.13.5 UAS Labs Key News
7.14 Biose
7.14.1 Biose Corporate Summary
7.14.2 Biose Business Overview
7.14.3 Biose Living Biological Drugs Major Product Offerings
7.14.4 Biose Living Biological Drugs Revenue in Global Market (2018-2023)
7.14.5 Biose Key News
7.15 Cerbios-Pharma
7.15.1 Cerbios-Pharma Corporate Summary
7.15.2 Cerbios-Pharma Business Overview
7.15.3 Cerbios-Pharma Living Biological Drugs Major Product Offerings
7.15.4 Cerbios-Pharma Living Biological Drugs Revenue in Global Market (2018-2023)
7.15.5 Cerbios-Pharma Key News
7.16 Inpac Probiotics
7.16.1 Inpac Probiotics Corporate Summary
7.16.2 Inpac Probiotics Business Overview
7.16.3 Inpac Probiotics Living Biological Drugs Major Product Offerings
7.16.4 Inpac Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.16.5 Inpac Probiotics Key News
7.17 NIZO
7.17.1 NIZO Corporate Summary
7.17.2 NIZO Business Overview
7.17.3 NIZO Living Biological Drugs Major Product Offerings
7.17.4 NIZO Living Biological Drugs Revenue in Global Market (2018-2023)
7.17.5 NIZO Key News
7.18 Winclove Probiotics
7.18.1 Winclove Probiotics Corporate Summary
7.18.2 Winclove Probiotics Business Overview
7.18.3 Winclove Probiotics Living Biological Drugs Major Product Offerings
7.18.4 Winclove Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.18.5 Winclove Probiotics Key News
7.19 BJP Laboratories
7.19.1 BJP Laboratories Corporate Summary
7.19.2 BJP Laboratories Business Overview
7.19.3 BJP Laboratories Living Biological Drugs Major Product Offerings
7.19.4 BJP Laboratories Living Biological Drugs Revenue in Global Market (2018-2023)
7.19.5 BJP Laboratories Key News
7.20 Luina Bio
7.20.1 Luina Bio Corporate Summary
7.20.2 Luina Bio Business Overview
7.20.3 Luina Bio Living Biological Drugs Major Product Offerings
7.20.4 Luina Bio Living Biological Drugs Revenue in Global Market (2018-2023)
7.20.5 Luina Bio Key News
7.21 List Labs
7.21.1 List Labs Corporate Summary
7.21.2 List Labs Business Overview
7.21.3 List Labs Living Biological Drugs Major Product Offerings
7.21.4 List Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.21.5 List Labs Key News
7.22 MatriSys Bioscience
7.22.1 MatriSys Bioscience Corporate Summary
7.22.2 MatriSys Bioscience Business Overview
7.22.3 MatriSys Bioscience Living Biological Drugs Major Product Offerings
7.22.4 MatriSys Bioscience Living Biological Drugs Revenue in Global Market (2018-2023)
7.22.5 MatriSys Bioscience Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
